{"title":"PAKISTAN’S PERSPECTIVE ON COVID-19 VACCINES","authors":"Taimoor Hassan, Saleha Saleha","doi":"10.46903/gjms/19.03.1016","DOIUrl":null,"url":null,"abstract":"As of May 10, 2021, the entire planet has reported approximately 188 million COVID-19 cases, with 2.54 million fatalities. Initially, lockdowns and softening measures have been thrown into turmoil throughout the world since the outbreak. Our social life will only return to normal once an appropriate vaccine is produced and proper authorized preventive techniques are implemented. To tackle this pandemic, governments and health experts all around the globe are experimenting with a range of measures and preventative strategies. Certain nations are considered to be more successful than others in terms of providing safety to their inhabitants and increasing their economic activities. A plethora of vaccinations have been produced, and a research anthology has been published. However, medical personnel are still searching for a viable treatment to limit this pandemic. Till date, only 5 vaccines have been approved by WHO for emergency use that includes Pfizer-BioNTech, Moderna, AstraZeneca, Sinopharm, Johnson & Johnson. Currently, confusing information about the COVID-19 vaccination is being disseminated across the world. During health emergency, rumors spread and caused panic, insanity, and anxiety. SARS-CoV-2 strains, on the other hand, are constantly appearing over the world. This article provides a Pakistan’s perspective towards COVID-19 vaccines with an updated review.","PeriodicalId":44174,"journal":{"name":"Gomal Journal of Medical Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gomal Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46903/gjms/19.03.1016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
As of May 10, 2021, the entire planet has reported approximately 188 million COVID-19 cases, with 2.54 million fatalities. Initially, lockdowns and softening measures have been thrown into turmoil throughout the world since the outbreak. Our social life will only return to normal once an appropriate vaccine is produced and proper authorized preventive techniques are implemented. To tackle this pandemic, governments and health experts all around the globe are experimenting with a range of measures and preventative strategies. Certain nations are considered to be more successful than others in terms of providing safety to their inhabitants and increasing their economic activities. A plethora of vaccinations have been produced, and a research anthology has been published. However, medical personnel are still searching for a viable treatment to limit this pandemic. Till date, only 5 vaccines have been approved by WHO for emergency use that includes Pfizer-BioNTech, Moderna, AstraZeneca, Sinopharm, Johnson & Johnson. Currently, confusing information about the COVID-19 vaccination is being disseminated across the world. During health emergency, rumors spread and caused panic, insanity, and anxiety. SARS-CoV-2 strains, on the other hand, are constantly appearing over the world. This article provides a Pakistan’s perspective towards COVID-19 vaccines with an updated review.